CandlesenseCandlesense
GSK•benzinga•

New Study Shows Shingles Vaccine Linked To 20% Lower Dementia Risk, GSK Stock Pops

Summary

A study of over 280,000 adults found that the shingles vaccine reduced dementia risk by 20%, with a stronger effect in women.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on April 3, 2025 by benzinga

← Back to GSK News
    New Study Shows Shingles Vaccine Linked To 20% Lower Dementia Risk, GSK Stock Pops | GSK Stock News | Candlesense